NCT06692738 · Interventional trial
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Overall registry status Recruiting
Phase 3
Conditions Non-small Cell Lung Cancer
Delaware Valley sites
- Research Site · Camden, NJ · Camden County · Recruiting
First posted
Registry updated
Added to the directory